Adachi H, Hayashi H, Sato H, Dempo K, Akino T
Department of Biochemistry, Sapporo Medical College, Japan.
Biochem J. 1989 Sep 15;262(3):781-6. doi: 10.1042/bj2620781.
Phospholipids in the lung fractions, i.e. alveolar free cells, extracellular pulmonary surfactant, intracellular pulmonary surfactant (lamellar bodies) and microsomal fractions, of rats were examined 28 days after intratracheal injection of silica (40 mg/kg). Significant accumulations of phospholipids were observed in the extracellular- and intracellular-surfactant fractions of rats exposed to silica. The prominent phospholipid accumulated was phosphatidylcholine (PC), consisting mainly of the dipalmitoyl species. However, a compositional change in acidic phospholipids of surfactant fractions was produced by the silica treatment. The percentage of phosphatidylglycerol (PG) was significantly decreased; in contrast, that of phosphatidylinositol (PI) was increased. Thus the ratio PG/PI in the surfactant fractions was markedly decreased in response to silica. This compositional change in both acidic phospholipids occurred even in the early stages, i.e. before appreciable accumulations of alveolar phospholipids were noticed. The molecular-species profiles of both acidic phospholipids in the surfactant fractions were distinctly different from each other. The dipalmitoyl species accounted for more than 30% of PG and less than 6% of PI, respectively. These species patterns of PG and PI were similar in control and silica-treated rats. These findings suggest two possibilities that (1) PG and PI destined for pulmonary surfactant are synthesized from each specific CDP-diacylglycerol (DG) pool having different molecular species in the lung, or (2) individual enzymes responsible for synthesis of surfactant PG and PI have substrate specificities for molecular species of CDP-DG, thereby producing PG and PI having different molecular species in surfactant compartments.
在气管内注射二氧化硅(40mg/kg)28天后,对大鼠肺部分(即肺泡游离细胞、细胞外肺表面活性物质、细胞内肺表面活性物质(板层小体)和微粒体部分)中的磷脂进行了检测。在暴露于二氧化硅的大鼠的细胞外和细胞内表面活性物质部分观察到磷脂的显著积累。积累的主要磷脂是磷脂酰胆碱(PC),主要由二棕榈酰磷脂酰胆碱组成。然而,二氧化硅处理导致表面活性物质部分的酸性磷脂组成发生变化。磷脂酰甘油(PG)的百分比显著降低;相反,磷脂酰肌醇(PI)的百分比增加。因此,响应二氧化硅,表面活性物质部分中PG/PI的比率显著降低。即使在早期阶段,即在肺泡磷脂明显积累之前,两种酸性磷脂的这种组成变化就已发生。表面活性物质部分中两种酸性磷脂的分子种类分布彼此明显不同。二棕榈酰磷脂酰甘油分别占PG的30%以上和PI的6%以下。PG和PI的这些种类模式在对照大鼠和二氧化硅处理的大鼠中相似。这些发现提示了两种可能性:(1)用于肺表面活性物质的PG和PI是由肺中具有不同分子种类的每个特定的CDP - 二酰甘油(DG)池合成的;或者(2)负责合成表面活性物质PG和PI的各个酶对CDP - DG的分子种类具有底物特异性,从而在表面活性物质区室中产生具有不同分子种类的PG和PI。